Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients
Conditions: Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Insulin-Dependent Interventions: Biological: Intravenous Injection of autologous mesenchymal stem cells; Other: Intravenous injection of placebo Sponsors: Royan Institute; Tehran University of Medical Sciences; Iranian Stem Cell Council Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 1 | Endocrinology | Insulin | Research | Stem Cell Therapy | Stem Cells | Transplants